Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target
- 7 January 2021
- journal article
- editorial
- Published by Springer Nature in Nature Genetics
- Vol. 53 (1) , 9-10
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- RAS: Striking at the Core of the Oncogenic CircuitryFrontiers in Oncology, 2019
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screeningeLife, 2016
- Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer CellsCell Reports, 2016
- Metabolic Dependencies in RAS-Driven CancersClinical Cancer Research, 2015
- Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like PropertiesCell, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonNature Genetics, 2008
- A genetic model for colorectal tumorigenesisCell, 1990
- On the Origin of Cancer CellsScience, 1956